Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Post by LannyMcdonaldon May 01, 2017 9:24am
183 Views
Post# 26186178

Diagnos - Google - IBM

Diagnos - Google - IBMhttps://www.artificialintelligenceonline.com/39423/ibm-machine-vision-technology-advances-early-detection-of-diabetic-eye-disease-using-deep-learning/....................Currently, DR (Diabetic Retinopathy) is diagnosed through regular screening of diabetes patients, where an expert clinician examines specialized fundus photography of the retina to identify the presence of lesions..... Interpreting these images requires specialized training and is often a manual, time-intensive and subjective process to rate them for the disease presence and severity............. About 90% of the worlds visually impaired live in low-income settings and developing countries, some with limited access to transportation and specialists..........Emerging computer vision methods to identify and classify lesions in an image within 20 seconds could create new levels of efficiency, which could help clinicians screen a greater number of diabetes patients, and quickly refer those who need specialist care............. Recent advancements in deep learning and image analytics technologies are showing significant promise in the potential to help solve some of the greatest health challenges we face today, said Dr. Joanna Batstone, Vice President and Lab Director of IBM Research Australia. Automated and highly accurate DR screening methods have the potential to help doctors screen far more patients than currently possible......... Diagnos Google IBM , all agree that DR screening using Artificial Intelligence is the way of the future and Im happy to say that Diagnos is pioneering the lead on this, as Google and IBM are still in the testing stages........ Regardless of who gets what of the global pie, theres lots to go round!
Bullboard Posts